These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 32279876)
1. Diagnosis of active tuberculosis and latent tuberculosis infection based on Raman spectroscopy and surface-enhanced Raman spectroscopy. Kaewseekhao B; Nuntawong N; Eiamchai P; Roytrakul S; Reechaipichitkul W; Faksri K Tuberculosis (Edinb); 2020 Mar; 121():101916. PubMed ID: 32279876 [TBL] [Abstract][Full Text] [Related]
2. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status. Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942 [TBL] [Abstract][Full Text] [Related]
3. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype. Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785 [TBL] [Abstract][Full Text] [Related]
4. Differential diagnostic value of simultaneous detection of CD69 and HLA-DR on host T and NK cells in QFT-TB assay for identifying active tuberculosis. Yang Y; Zhang F; Shi H; Zhu Z; Zhou Y; Zhou Y Tuberculosis (Edinb); 2024 Sep; 148():102537. PubMed ID: 38954896 [TBL] [Abstract][Full Text] [Related]
5. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation. Sun Q; Wei W; Sha W PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330 [TBL] [Abstract][Full Text] [Related]
6. Microarray-based selection of a serum biomarker panel that can discriminate between latent and active pulmonary TB. Li Z; Hu J; Liu P; Cui D; Di H; Wu S Sci Rep; 2021 Jul; 11(1):14516. PubMed ID: 34267288 [TBL] [Abstract][Full Text] [Related]
7. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection. Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795 [TBL] [Abstract][Full Text] [Related]
8. Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy. Zhou Y; Du J; Hou HY; Lu YF; Yu J; Mao LY; Wang F; Sun ZY Front Cell Infect Microbiol; 2017; 7():457. PubMed ID: 29164066 [TBL] [Abstract][Full Text] [Related]
9. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection. Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500 [TBL] [Abstract][Full Text] [Related]
10. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country? Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095 [TBL] [Abstract][Full Text] [Related]
11. Dataset of serum proteomic spectra from tuberculosis patients detected by Raman spectroscopy and surface-enhanced Raman spectroscopy. Kaewseekhao B; Nuntawong N; Eiamchai P; Roytrakul S; Reechaipichitkul W; Faksri K Data Brief; 2020 Feb; 28():104891. PubMed ID: 31867423 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of interferon (IFN)-γ inducible protein 10 (IP-10) as a biomarker for the discrimination of active and latent tuberculosis. Mamishi S; Mahmoudi S; Banar M; Hosseinpour Sadeghi R; Marjani M; Pourakbari B Mol Biol Rep; 2019 Dec; 46(6):6263-6269. PubMed ID: 31564016 [TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis. Davidow AL Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015 [TBL] [Abstract][Full Text] [Related]
14. Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection. Yang X; Wu JB; Liu Y; Xiong Y; Ji P; Wang SJ; Chen Y; Zhao GP; Lu SH; Wang Y Tuberculosis (Edinb); 2017 Dec; 107():119-125. PubMed ID: 29050758 [TBL] [Abstract][Full Text] [Related]
15. A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study. Li H; Ren W; Liang Q; Zhang X; Li Q; Shang Y; Ma L; Li S; Pang Y QJM; 2023 Dec; 116(12):1002-1009. PubMed ID: 37740371 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection. Petrone L; Vanini V; Chiacchio T; Petruccioli E; Cuzzi G; Schininà V; Palmieri F; Ippolito G; Goletti D Tuberculosis (Edinb); 2018 Jul; 111():147-153. PubMed ID: 30029901 [TBL] [Abstract][Full Text] [Related]
17. Multiplex analysis of plasma cytokines/chemokines showing different immune responses in active TB patients, latent TB infection and healthy participants. Yao X; Liu Y; Liu Y; Liu W; Ye Z; Zheng C; Ge S Tuberculosis (Edinb); 2017 Dec; 107():88-94. PubMed ID: 29050777 [TBL] [Abstract][Full Text] [Related]
19. Prediction of Th1 and Cytotoxic T Lymphocyte Epitopes of Gong W; Liang Y; Wang J; Liu Y; Xue Y; Mi J; Li P; Wang X; Wang L; Wu X Microbiol Spectr; 2022 Aug; 10(4):e0143822. PubMed ID: 35938824 [TBL] [Abstract][Full Text] [Related]
20. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection. Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]